Skip to contentApplication 072691
- Type
- ANDA
- Sponsor
- WATSON LABS
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | AMOXAPINE | AMOXAPINE | TABLET;ORAL | 150MG | No | Yes |
| 002 | AMOXAPINE | AMOXAPINE | TABLET;ORAL | 25MG | No | No |
| 003 | AMOXAPINE | AMOXAPINE | TABLET;ORAL | 50MG | No | No |
| 004 | AMOXAPINE | AMOXAPINE | TABLET;ORAL | 100MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0591-5713 | Amoxapine | Amoxapine | Actavis Pharma, Inc. | ANDA | Current |
| 0591-5713 | Amoxapine | Amoxapine | Actavis Pharma, Inc. | ANDA | Current |
| 0591-5714 | Amoxapine | Amoxapine | Actavis Pharma, Inc. | ANDA | Current |
| 0591-5714 | Amoxapine | Amoxapine | Actavis Pharma, Inc. | ANDA | Current |
| 0591-5715 | Amoxapine | Amoxapine | Actavis Pharma, Inc. | ANDA | Current |
| 0591-5715 | Amoxapine | Amoxapine | Actavis Pharma, Inc. | ANDA | Current |
| 0591-5716 | Amoxapine | Amoxapine | Actavis Pharma, Inc. | ANDA | Current |
| 0591-5716 | Amoxapine | Amoxapine | Actavis Pharma, Inc. | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 18350 | SUPPL | 2014-09-05 |